Immatics N.V. Ordinary Shares

IMTXNASDAQUSD
10.45 USD
0.10 (0.96%)🟢LIVE (AS OF 11:26 AM EDT)
🟢Market: OPEN
Open?$10.42
High?$10.63
Low?$9.42
Prev. Close?$10.35
Volume?107.9K
Avg. Volume?N/A
VWAP?$10.50
Bid / Ask
Bid?$9.03 × 100
Ask?$10.49 × 100
Spread?$1.46
Midpoint?$9.76
Valuation & Ratios
Market Cap?1.4B
Shares Out?134.1M
Float?91.6M
Float %?75.3%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
Loading...
News
Profile
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
Employees
407
Market Cap
1.4B
Industry
N/A
Listed
2020-07-02